A recent study found that JAK inhibitors don’t increase the risk of cardiac problems

Rates of venous thromboembolism (VTE) were also similar (adjusted HR 1.1, 95% CI 0.7-1.6) in the study of nearly 16,000 rheumatoid arthritis patients, the researchers¬†reported in¬†Annals of the Rheumatic Diseases. An examination of French national registry data revealed that patients taking Janus kinase (JAK) inhibitors for rheumatoid arthritis had cardiovascular results comparable to those of […]

Scroll to top
Social media & sharing icons powered by UltimatelySocial

Enjoy this blog? Please spread the word :)